Supernus Pharmaceuticals, Inc.
$2.45B- Market cap
- $2.53B
- Debt
- +$43.80M
- Cash
- −$128.45M
Capital structure 98% equity / 2% debt · EV / Revenue 3.40x · EV / EBITDA 50.55x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
SUPN · current priceP/S 3.52x
$43.55Latest market snapshot
Implied fair value · at SIRI's multiple
$14.1367.5% below market
12.37 SUPN revenue / share×1.14x SIRI P/S=$14.13
Market $43.55Implied $14.13
SIRI · current priceP/S 1.14x
$29.01Latest market snapshot
Implied fair value · at SUPN's multiple
$89.40208.2% above market
25.39 SIRI revenue / share×3.52x SUPN P/S=$89.40
Market $29.01Implied $89.40